Song Wu

VP, GPL, Global Head of Project Development and Management @ Hansoh Pharm/Hansoh Bio

About

Drug Discovery / Project Management / Clinical Research / Translational Medicine / Biomarker Discovery / Bioinformatics / Genomics / Data Science scientist worked in R&D pharma MNC Company with >20 years broad experience and epic science in Oncology / Autoimmune / CVRM / CNS research and clinical development. Extensive experience in discovering preclinical targets, translational research, clinical development, and biomarkers discoveries in cell signaling, epigenetics, metabolic pathways and immno-oncology. Strong experience in understanding the cancer heterogeneity and mechanisms using next generation genomic/proteomic data and integrated informatics platforms; Demonstrated to be capable of developing R&D strategies, managing “complex data” systems and multiple projects and to drive life-cycle developments of the projects. Specialties: Artificial Intelligence (Deep Learning / Deep Neural Network) Immuno-Oncology / Oncology Research Bioinformatics Translational Research Translational Medicine Clinical Development Biomarker Discovery ADC and TCE

Country

United States

City

Rockville

Industry

Pharmaceuticals

Skill

Drug Discovery, Bioinformatics, Biomarkers, Genomics, Life Sciences, Oncology, Cancer, Clinical Development, Lifesciences, Assay Development, Clinical Trials, Biotechnology, Molecular Biology, Biostatistics, Clinical Research, Cell, Drug Development, Data Analysis, Cell Culture, R&D

Experience

VP, GPL, Global Head of Project Development and Management

Hansoh Pharm/Hansoh Bio

2023-12 - Present · 2 yrs 10 mos

Washington DC-Baltimore Area

Head of Translational Oncology

Hansoh Pharm/Hansoh Bio

2021-8 - 2023-12 · 2 yrs 5 mos

Washington DC-Baltimore Area

Director

AstraZeneca

2019-12 - 2021-8 · 1 yr 9 mos

Washington DC-Baltimore Area

Senior Scientist

MedImmune

2015-8 - 2019-12 · 4 yrs 5 mos

Washington D.C. Metro Area

Clinical Biomarker Bioinformatics Translational Research

Research Scientist

Eli Lilly and Company

2011-2 - 2015-8 · 4 yrs 7 mos

Indianapolis, Indiana Area

- Cancer Informatics / Genomics - Oncology Biomarker Discovery (Cell Cycle Inhs, Signaling Pathway Targets, Immuno-Checkpoints and Development Pathway Targets etc.) - Clinical Genomics and NGS based Clinical Trial Design - Target Identification and Validation - Colon Cancer Research

Principle Associate Scientist (Systems Biology)

Eli Lilly and Company

2005-8 - 2011-2 · 5 yrs 7 mos

Singapore

- Oncology (clinical) biomarker discovery and drug combination studies - Data analysis of several large scale genomics platforms and in vitro/in vivo assays and to propose (clinical) candidate biomarkers. - Developed genomic signature based approach to guide the clinical development - Developed new bioinformatics method/algorithm in biomarker study

Research Associate

Bioinformatics Institute of Singapore

2003-7 - 2005-8 · 2 yrs 2 mos

Singapore

- Sequence analysis - Gene expression data analysis - Modeling and simulation: PI3K/Akt pathway - Modeling methods study: ODE, Stochastic Simulation, Fuzzy Logic

Education

National University of Singapore

Biological Science

2007 - 2011 · 4 yrs

National University of Singapore

High Performance Computation for Engineered System

2002 - 2003 · 1 yr

SMA, Singapore-MIT Alliance, is an innovative engineering and life science educational and research collaboration among three leading research universities in the world: the National University of Singapore (NUS), the Nanyang Technological University (NTU), and the Massachusetts Institute of Technology (MIT)(web.mit.edu/sma/).